Oxford Endovascular is a spin out from Oxford University developing technology to prevent brain haemorrhage. OxiFlow™️ is a novel, next generation flow-diverter, laser-cut from nitinol that diverts blood flow away from intracranial aneurysms at risk of rupture. Competitors have adverse events related to poor placement of devices due to their inherent design weaknesses. OxiFlow™️ is a unique design that places more accurately and safely than existing products, reducing risk of complications and conforms to blood vessel shapes making more patients treatable. Patented in Europe, US, China & Japan. Created by world experts in the field, OxiFlow™ has gone through proof of concept pre-clinical studies that will be followed by a 1st in human study en-route to gaining FDA & CE mark.
External link for Oxford Endovascular Ltd.
Oxford Science Park
Oxford, GB
HealthTech Entrepreneur, Business Growth/Transformation, Fundraising Solutions, Consulting
Oxford Endovascular, presenting at LSI USA 2024: Please see our presentation on 'Origami Engineering to treat Brain Aneurysms' - overcoming the placement and opening challenges of existing flow diverter devices. Our journey continues, following recently successfully raising ongoing funds, supporting our development! https://lnkd.in/e5tYz6tJ @LSI - Life Science Intelligence #LSIUSA23
HealthTech Entrepreneur, Business Growth/Transformation, Fundraising Solutions, Consulting
Thanks to the LSI team for organising such a great session for Oxford Endovascular to present on 'Origami Engineering' to treat Brain aneurysms at LSI 2024. Lots of positive feedback on our technology afterwards, as we progress on our journey towards the clinic!
HealthTech Entrepreneur, Business Growth/Transformation, Fundraising Solutions, Consulting
Honoured to be invited to present at LSI USA 24 to update on Oxford Endovascular's mission to improve treatment for Brain Aneurysms using Origami Engineering in its next generation Flow Diverter! @LSI #lsiusa24 #LSIALUMNI #medtech